News & events

Behind every treatment that improves health, is a story of discovery. Read our stories here.

Professor Gail Risbridger (left) and Renea Taylor (right), co-leads of the Prostate Cancer Research Group

Overcoming tumour barriers for CAR T cell therapy in prostate cancer

A strategic collaboration between Monash Biomedicine Discovery Institute and Peter MacCallum Cancer Centre’s Immunology Program has discovered a novel way in which solid cancers may be made responsive to immunotherapy.

Biomedicine Discovery Institute 20 September 2023

Cancer drug dampens COVID-related inflammation

Dr Dominic De Nardo is a Group Leader in the Department of Biochemistry & Molecular Biology, Immunity Program within the Monash Biomedicine Discovery Institute.

A cancer drug could play an important role in limiting the damaging effects of inflammation in COVID-19 patients, thanks to new research co-led by Hudson Institute of Medical Research, Monash University and the Centenary Institute.

Biomedicine Discovery Institute 19 September 2023

Researchers create “Lipidomic Map,” offering insights into immunology

An international team of scientists has developed a method for simultaneously detecting thousands of lipid molecules that are displayed to T cells in the human immune system.

Biomedicine Discovery Institute 19 September 2023

Developing AI to help identify at-risk bowel cancer patients

A Cabrini Health-Monash Biomedicine Discovery Institute (BDI) partnership will be using Artificial Intelligence (AI) to develop a method for predicting which bowel cancer patients are at risk of relapse after treatment by surgery.

Biomedicine Discovery Institute 12 September 2023

Dr Lan Nguyen (left) and his PhD student, Anthony Hart (right) who has recently submitted his PhD

Predicting when a cancer will be resistant to drugs

Monash researchers have developed a framework to predict first, how a cancer will become resistant to a drug, and second - given that everyone is different - what the significant differences are that allow some cancers to resist the drug.

Biomedicine Discovery Institute 11 September 2023

View more articles